The 35th CINP World Congress of Neuropsychopharmacology

Presentation information

[CINP2024] Short Communications

CINP2024 » Short Communications

Short Communications 3
Depression 1 - Clinical (1)

Fri. May 24, 2024 10:45 AM - 12:10 PM Room 8 (G405)

Chair: Michael Berk (Deakin University)

[SC3-3] Lumateperone Treatment for Major Depressive Episodes with Mixed Features in Major Depressive Disorder and Bipolar I or Bipolar II Disorder

*Zubin Bhagwagar1, Susan G. Kozauer1, Willie R. Earley1, Changzheng Chen1, Jason Huo1, Stephen Stahl2, Roger S. McIntyre3,4, Suresh Durgam1 (1. Intra-Cellular Therapies Inc., New York, NY, USA, 2. Department of Psychiatry, University of California, San Diego; La Jolla, CA, USA, 3. Department of Psychiatry, University of Toronto, Toronto, ON, Canada, 4. Department of Pharmacology, University of Toronto, Toronto, ON, Canada)

Keywords:lumateperone, major depressive disorder, bipolar disorder, mixed features

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Password